Cebiotex is a clinical-stage biotechnology company dedicated to advancing oncology therapies, focusing on addressing unmet needs through locally released formulations of anti-cancer agents
Cebiotex is a clinical-stage biotechnology company dedicated to advancing oncology therapies, focusing on addressing unmet needs through locally released formulations of anti-cancer agents. Their lead product, CEB-01, is a nanofiber membrane loaded with the chemotherapeutic drug SN-38, designed for post-surgical cancer treatment.